Exelixis

Exelixis keeps cards close
Minyanville
Thu, 05/19/11 - 01:53 pm
Exelixis
cabozantinib
Exelixis: Looming Cancer Conference a Favorable Swing Trade Opportunity
Seeking Alpha
Mon, 05/16/11 - 09:33 am
Exelixis
cancer
tyrosine kinases
Ariad and Exelixis Look to Shine at Upcoming Trade Show
Seeking Alpha
Thu, 05/12/11 - 11:48 am
Ariad Pharmaceuticals
Exelixis
ridaforolimus
cancer
cabozantinib
Exelixis' CEO Discusses Q1 2011 Results - Earnings Call Transcript
Seeking Alpha
Wed, 05/4/11 - 09:57 am
earnings
Exelixis
Exelixis spurs takeover rumors with Goldman ploy
Fierce Biotech
Tue, 04/12/11 - 10:17 am
prostate cancer
Exelixis
cabozantinib
10 promising late-stage cancer drugs
Fierce Biotech
Tue, 04/5/11 - 10:47 pm
cancer
Carfilzomib
crizotinib
vismodegib
Oncovex
PLX4032
Ponatinib
SGN-35
tivozanib
T-DM1
cabozantinib
ONYX Pharmaceuticals
Pfizer
Genentech
Curis
Amgen
Plexxikon
Seattle Genetics
Ariad Pharmaceuticals
Aveo Pharmaceutical
Exelixis
Roche
The 15 Most-Watched Biotech Stocks
Motley Fool
Mon, 04/4/11 - 11:06 pm
Gilead Sciences
Exelixis
Amgen
Dendreon
Immunogen
Maxygen
MannKind
PDL Biopharma
Celgene
Geron
Vertex Pharmaceuticals
Arena Pharmaceuticals
Human Genome Sciences
Orexigen
Biogen Idec
Cancer Drug Stocks to Trade Ahead of ASCO
TheStreet.com
Tue, 03/22/11 - 10:03 am
ASCO
Medivation
Exelixis
Dendreon
Bristol-Myers Squibb
Roche
Curis
Celgene
Sanofi
Ariad Pharmaceuticals
Merck
Incyte
Novartis
YM BioSciences
Pfizer
Aveo Pharmaceutical
ONYX Pharmaceuticals
Amgen
Synta
Vical
Oxigene
Cell Therapeutics
Oncothyreon
Exelixis plans $165M stock sale
Bizjournals.com
Thu, 03/10/11 - 10:23 am
Exelixis
stock offering
Exelixis Slides on Stock Sale Plans
TheStreet.com
Tue, 03/8/11 - 07:57 am
stock offering
Exelixis
Battered but Unbroken Biotechs
Seeking Alpha
Tue, 03/1/11 - 10:26 am
Amylin
Alnylam
Celldex
Exelixis
Human Genome Sciences
Isis Pharmaceuticals
Lexicon Pharmaceuticals
Neurocrine
Nektar
ONYX Pharmaceuticals
Ziopharm
Seattle Genetics
Exelixis: Going Where No Drug Has Gone Before
Seeking Alpha
Wed, 02/23/11 - 10:47 pm
Exelixis
cabozantinib
prostate cancer
Exelixis Q4 loss narrows to $17.9M
Yahoo/AP
Wed, 02/23/11 - 08:06 am
earnings
Exelixis
Exelixis seen narrowing Q4 loss, increasing revenue
Bizjournals.com
Tue, 02/22/11 - 09:28 am
earnings
Exelixis
Exelixis shares rise after report on cancer drug
Yahoo/AP
Sat, 02/19/11 - 11:38 am
Exelixis
prostate cancer
cabozantinib
Top Biotech Takeout Targets in 2011
Minyanville
Fri, 02/18/11 - 03:32 pm
M&A
biotech
Biogen Idec
Human Genome
Seattle Genetics
GSK
Dendreon
Actelion
Biomarin
Exelixis
Vertex Pharmaceuticals
Celgene
Alexion
Shire
InterMune
Lexicon Pharmaceuticals
Savient
Merck KGaA
Exelixis: A Successful Development Stage Biotech Firm
Seeking Alpha
Mon, 02/14/11 - 05:56 pm
Exelixis
Value Investing, Biotech Style
Motley Fool
Sat, 01/29/11 - 11:35 am
investors
Benlysta
Human Genome Sciences
GSK
Cell Therapeutics
obesity. Orexigen Therapeutics
Vertex Pharmaceuticals
Exelixis
Smart Money's 9 Top Biotech Stock Picks
Seeking Alpha
Mon, 01/17/11 - 12:53 pm
biotech
Cadence Pharmaceuticals
Cell Therapeutics
Enzon
Geron
Exelixis
Seattle Genetics
Savient
Vivus
Theravance
Exelixis cancer drug wins 'orphan' tag
Bizjournals.com
Mon, 01/10/11 - 12:35 pm
Exelixis
orphan drugs
XL-184
thyroid cancer

Pages